聚(L-乳酸), Poly(L-lactide), medical grade, end group: carboxyl, average M.W. 360,000 - 480,000

(R)-N-((R)-(2-(二苯基磷烷基)苯基)(4-甲氧基苯基)甲基)-2-甲基丙烷-2-亚磺酰胺, (R)-N-((R)-(2-(diphenylphosphanyl) phenyl)(4-methoxyphenyl)methyl)-2-methylpropane-2-sulfinamide

(R)-N-((S)-(3,5-二叔丁基-4-甲氧基苯基)(2-(二苯基磷烷基)苯基)甲基)-N,2-二甲基丙烷-2-亚磺酰胺, (R)-N-((S)-(3,5-di-tert-butyl-4-methoxyphenyl)(2-(diphenyl phosphanyl)phenyl)methyl)-N,2-dimethylpropane-2-sulfinamide

(R)-N-((S)-(6-(二苯基膦基)苯并[d][1,3]二氧杂环戊烯-5-基)(萘-1-基)甲基)-2-甲基丙烷-2-亚磺酰胺, (R)-N-((S)-(6-(Diphenylphosphanyl)benzo[d][1,3]dioxol-5-yl)(naph thalen-1-yl)methyl)-2-methylpropane-2-sulfinamide

(R)-N-((S)-1-(二苯基膦基)-3,3-二甲基丁-2-基)-2-甲基丙烷-2-亚磺酰胺, (R)-N-((S)-1-(Diphenylphosphanyl)-3,3-dimethylbutan-2-yl)-2-methylpropane-2-sulfinamide

(Rs)-N-((S)-(5-(二苯基膦)-9,9-二甲基-9H-呫吨-4-基)(萘-1-基)甲基)-2-甲基丙烷-2-亚磺酰胺, (Rs)-N-((S)-(5-(Diphenylphosphanyl)-9,9-dimethyl-9H-xanthen-4-yl)(naphthalen-1-yl)methyl)-2-methylpropane-2-sulfinamide

(Rs)-N-((S)-1-(5-(二苯基磷烷基)-9,9-二甲基-9H-黄嘌呤-4-基)-2,2-二甲基丙基)-2-甲基丙烷-2-亚磺酰胺, (Rs)-N-((S)-1-(5-(Diphenylphosphanyl) -9,9-dimethyl-9H-xanthen-4-yl)-2,2-dimethylpropyl)-2-methylpropane-2-sulfinamide

(R)-N-((R)-(2-(2-(二环己基磷酰基)苯基)(萘-2-基)甲基)-2-甲基丙烷-2-亚磺酰胺, (R)-N-((R)-(2-(Dicyclohexyl phosphanyl)phenyl)(naphthalen-2-yl)methyl)-2-methylpropane-2-sulfinamide

(R)-N-((S)-(2-(二((1S,3R,5S,7S)-金刚烷-1-基)磷烷基)苯基)(苯基)甲基)-N,2-二甲基丙烷-2-亚磺酰胺, (R)-N-((S)-(2-(Di((1S,3R,5S,7S)-adamantan-1-yl)phosphanyl) phenyl)(phenyl)methyl)-N,2-dimethylpropane-2-sulfinamide

(R)-N-((S)-(2-(二((1S,3R,5S,7S)-金刚烷-1-基)磷烷基)苯基)(苯基)甲基)-2-甲基丙烷-2-亚磺酰胺, (R)-N-((S)-(2-(Di((1S,3R,5S,7S)-adamantan-1-yl)phosphanyl) phenyl)(phenyl)methyl)-2-methylpropane-2-sulfinamide